THYMUS VULGARIS LEAF OIL
Huile essentielle extraite des feuilles du thym commun, une plante aromatique méditerranéenne. Elle exerce une fonction antioxydante et conservatrice dans les formulations cosmétiques.
Roles & functions
Antioxidant — Limits oxidation and helps preserve the formula over time.
Preservative — Limits the growth of micro-organisms to preserve the product.
Dosage guidance
Precautions & sensitive groups
Precaution — In the absence of sufficient data, the HMPC advises against use during pregnancy. To be confirmed by the pharmacist. — source: EMA/HMPC — Thymi aetheroleum
Precaution — In the absence of sufficient data, the HMPC advises against use during breastfeeding. To be confirmed by the pharmacist. — source: EMA/HMPC — Thymi aetheroleum
Precaution — The HMPC does not recommend use in children under 18 years. To be confirmed by the pharmacist. — source: EMA/HMPC — Thymi aetheroleum
Precaution — The HMPC does not recommend use in children under 3 years. To be confirmed by the pharmacist. — source: EMA/HMPC — Thymi aetheroleum
Precaution — In the absence of sufficient data, the HMPC advises against use during breastfeeding. To be confirmed by the pharmacist. — source: EMA/HMPC — Thymi herba
Precaution — The HMPC does not recommend use in children under 12 years. To be confirmed by the pharmacist. — source: EMA/HMPC — Thymi herba
Precaution — In the absence of sufficient data, the HMPC advises against use during pregnancy. To be confirmed by the pharmacist. — source: EMA/HMPC — Thymi herba
What the authorities say
| Authority | Status |
|---|---|
| Commission européenne (CosIng, Règl. 1223/2009) | Autorisé |
| Classification CLP (Règl. 1272/2008) | No CMR classification |
| ECHA — perturbateur endocrinien (santé humaine) | Not identified as an endocrine disruptor |
| ECHA — Liste des substances candidates (SVHC, REACH Art. 59) | Not on the Candidate List (SVHC) |
| Commission européenne (Règl. 1223/2009, Annexe III) | No cosmetic allergen subject to mandatory labelling |
| Commission européenne (Catalogue UE des nanomatériaux, Règl. 1223/2009) | No referenced nanoform |
Who it is not recommended for
En l’absence de données suffisantes, l’HMPC déconseille l’usage pendant la grossesse. À confirmer par le pharmacien.
En l’absence de données suffisantes, l’HMPC déconseille l’usage pendant l’allaitement. À confirmer par le pharmacien.
L’HMPC ne recommande pas l’usage chez l’enfant de moins de 12 ans. À confirmer par le pharmacien.
A question about this ingredient?
Lou answers you and looks at your products with you, in store.